C12N 2710/16232
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/16232 (Use of virus as therapeutic agent, other than vaccine) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 6
- Assignees
- 3
- Inventors
- 9
- Latest grant
- 11 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Anti-abeta therapeutic vaccines11 Jun 2024US 12,005,102 B2AC Immune SA
- Anti-abeta therapeutic vaccines10 Nov 2020US 10,828,351 B2AC Immune SA
- Methods of producing and using regulatory B-cells25 Apr 2017US 9,629,897 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Compositions and methods for reducing cell therapy immunogenicity23 Oct 2025US 2025/0325585 A1The General Hospital Corporation
- Anti-Abeta Therapeutic Vaccines24 Oct 2024US 2024/0350598 A1AC Immune SA
- Anti-abeta therapeutic vaccines1 Apr 2021US 2021/0093700 A1AC Immune SA
- Anti-abeta therapeutic vaccines10 Oct 2019US 2019/0307867 A1AC Immune SA
- Methods of producing and using regulatory b-cells23 Apr 2015US 2015/0110737 A1The United States of America, as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents